Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03062917
Other study ID # 15/WM/0343
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 2, 2015
Est. completion date June 30, 2018

Study information

Verified date October 2019
Source Imperial College Healthcare NHS Trust
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will compare the novel methods of NS and BS with the standard technique of nasophayngeal aspiration (NPA) and routine ETT suction. We shall assess the samples for diagnosis of RSV, viral load and immune responses in the airways of babies with RSV infection. We shall also assess the genetics of babies included in this study, to see if they may be vulnerable to RSV infection.


Description:

In conjunction with a specialist medical device manufacturing company (Hunt Developments (Midhurst, West Sussex) we have produced novel nasosorption and bronchosorption kits that have CE marking. Both nasosorption and bronchosorption methods use synthetic absorptive matrix (SAM) strips: that look and feel like blotting paper, and will be placed onto the mucosal surface. These are comfortable to use and can be used at frequent intervals over extended periods of time. This non-invasive technique is ideal for infants and children, and it is possible to obtain neat mucosal lining fluid (MLF) even from normal healthy noses. The eluates contain cytokines and chemokines at high detectable levels on multiplex immunoassay.

We would like to use these SAMs to take MLF samples from the nasal and bronchial mucosal surfaces to see if these novel techniques can overcome the problems with current sampling methods. We plan to use these absorption techniques to measure RSV viral load. We also aim to look at the immune response in terms of the anti-viral interferon response (IFN-γ, IFN-λ, IFN-α2a, IP10, ITAC). In therapeutic studies in the future, it may be possible to document levels of drug (pharmacokinetics) in nasal MLF.


Recruitment information / eligibility

Status Completed
Enrollment 152
Est. completion date June 30, 2018
Est. primary completion date June 30, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A to 2 Years
Eligibility Group 1 and Group 2

Inclusion Criteria

- Infants aged 2 weeks-24 months

- Presentation to the Emergency Department with any upper respiratory tract infection (URTI) in the RSV season (Oct-March).

OR • Documented RSV infection, admitted to the paediatric wards at St Mary's Hospital.

Exclusion Criteria

- Any local or systemic factor that would influence the safety of nasal sampling.

- Bilateral indwelling nasal catheters or local nasal pathology preventing access for nasal sampling.

- Bleeding disorders.

- The baby is taking part in another interventional study.

- The parents or guardians not able to sign the informed consent from due to limited English or comprehension despite the use of independent interpreter services.

- Limited life expectancy of the baby,

Group 3

Inclusion criteria

- Hospitalised Infants admitted to the PICU at St. Mary's Hospital, aged 2 weeks-24 months with documented RSV infection (by rapid test and/or PCR).

- Infants of weight >2kg.

- On a conventional ventilator with an Endotracheal Tube (ETT) of >3.0mmm diameter

Exclusion criteria

- Any local or systemic factor that would influence the safety of nasal sampling.

- Bilateral nasal catheters or local nasal pathology preventing access for nasal sampling.

- The baby is taking part in another interventional study.

- Prematurity - corrected gestational age <36 weeks, weight <2kg

- Significant hypoxia or instability precluding ventilator disconnection

- ETT < 3mm internal diameter

- Transcutaneous oxygen saturation of <95% on 60% oxygen

- Risk of bleeding

- Pneumothorax

- Infants receiving oral corticosteroid therapy at any time in past month

- Parents or guardians not able to sign informed consent from due to limited English or understanding despite the use of independent interpreter services.

- Limited life expectancy or a decision to limit management,

Control Group 1 Inclusion criteria

• Babies, aged 2 weeks-24 months, attending routine outpatient appointments or undergoing elective surgical procedures.

Exclusion criteria

- Any respiratory symptoms

- All other exclusion are the same as Groups 1 and 2

Control Group 2

Inclusion criteria

- Infants aged 2 weeks-24 months.

- Infants ventilated on the PICU for any condition

- Confirmed RSV negative by PCR of respiratory tract samples

Exclusion Criteria

- All exclusions are the same as Group 3

- In addition - any concern about raised intracranial pressure

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Nasal and Bronchial Sampling
Nasal Absorption sampling, Bronchial sampling, Nasal Pharageal Aspirates, Blood sampling.

Locations

Country Name City State
United Kingdom Imperial College NHS Healthcare Trust London

Sponsors (2)

Lead Sponsor Collaborator
Imperial College Healthcare NHS Trust Pulmocide Ltd

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary The Number of Sampling Visits on Which Participants Are Willing to Undergo Nasosorption and/or NPA Sampling To determine the difference in tolerability of nasosorption compared to NPA by assessment of acceptance by infants and families. Samples were collected from participants up to twice daily throughout study involvement, as such each participant could have >1 sampling visits. Throughout symptomatic respiratory infection, up to 1 month
Primary Accuracy of Nasosorption for Viral Load Measurement To determine the difference in accuracy of nasosorption compared to NPA by assessment of level of viral load (measured by qPCR). Throughout symptomatic respiratory infection, up to 1 month
Primary Accuracy of Bronchosorption for Viral Load Measurement, Compared to Tracheal Aspirate To determine the difference in accuracy of bronchosorption (BSAM) compared to tracheal aspirate (TA) by assessment of level of viral load (measured by qPCR). Throughout symptomatic respiratory infection, up to 1 month
Secondary Immune Response Establishing the use of nasal and bronchial sampling to measure the host immune response to RSV. We will determine cytokine and inflammatory mediator concentrations by immunoassay of eluted fluid from nasosorption and compare with NPA. Throughout symptomatic respiratory infection, up to 1 month
See also
  Status Clinical Trial Phase
Completed NCT03909854 - Pragmatic Investigation of Volume Targeted Ventilation-1 N/A
Recruiting NCT03662438 - HOPE (Home-based Oxygen [Portable] and Exercise) for Patients on Long Term Oxygen Therapy (LTOT) N/A
Recruiting NCT05308719 - Nasal Oxygen Therapy After Cardiac Surgery N/A
Recruiting NCT05535543 - Change in the Phase III Slope of the Volumetric Capnography by Prone Positioning in Acute Respiratory Distress Syndrome
Completed NCT04030208 - Evaluating Safety and Efficacy of Umbulizer in Patients Requiring Intermittent Positive Pressure Ventilation N/A
Recruiting NCT04542096 - Real Time Evaluation of Dynamic Changes of the Lungs During Respiratory Support of VLBW Neonates Using EIT
Recruiting NCT04668313 - COVID-19 Advanced Respiratory Physiology (CARP) Study
Recruiting NCT05883137 - High-flow Nasal Oxygenation for Apnoeic Oxygenation During Intubation of the Critically Ill
Completed NCT04505592 - Tenecteplase in Patients With COVID-19 Phase 2
Completed NCT03943914 - Early Non-invasive Ventilation and High-flow Nasal Oxygen Therapy for Preventing Delayed Respiratory Failure in Hypoxemic Blunt Chest Trauma Patients. N/A
Active, not recruiting NCT03472768 - The Impact of Age-dependent Haptoglobin Deficiency on Plasma Free Hemoglobin Levels During Extracorporeal Membrane Oxygenation Support
Not yet recruiting NCT04538469 - Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff
Not yet recruiting NCT02542423 - Endocan Predictive Value in Postcardiac Surgery Acute Respiratory Failure. N/A
Completed NCT02265198 - Relationship of Pulmonary Contusion to Pulmonary Inflammation and Incidence of Acute Respiratory Distress Syndrome N/A
Completed NCT01885442 - TryCYCLE: A Pilot Study of Early In-bed Leg Cycle Ergometry in Mechanically Ventilated Patients N/A
Completed NCT02105298 - Effect of Volume and Type of Fluid on Postoperative Incidence of Respiratory Complications and Outcome (CRC-Study) N/A
Completed NCT01659268 - Performance of Baccalaureate Nursing Students in Insertion of Laryngeal Mask: a Trial in Mannequins N/A
Completed NCT02814994 - Respiratory System Compliance Guided VT in Moderate to Severe ARDS Patients N/A
Completed NCT01249794 - Non Invasive Ventilation After Cardiac Surgery N/A
Terminated NCT01333059 - Cycling of Sedative Infusions in Critically Ill Pediatric Patients N/A